Tel: +86-021-3762 1270
Fax: +86-021-6762 1877
Email: service@genicbio.com
FC131 TFA | {2-Naph-Ala}-{Gly}-{Tyr}-{Arg}-{Arg} |
(Arg)9 TFA | RRRRRRRRR |
(Glp1)-Apelin-13, human, bovine | Glp-RPRLSHKGPMPF |
(Met 210) Melanoctye Protein PMEL 17 (209-217) (human) | IMDQVPFSV |
[Ala1,3,11,15]-Endothelin TFA | ASASSLMDKEAVYFAHLDIIW |
[Ala9] Autocamtide 2 | KKALRRQEAVDAL |
[Arg8]-Vasotocin TFA | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2(Disulfide bridge:Cys1-Cys6) |
[Asp371]-Tyrosinase (369-377), human | YMDGTMSQV |
[bAla8]-Neurokinin A(4-10) | DSFV-{Bal}-LM-NH2 |
[Cys8] Renin Substrate Tetradecapeptide, rat | DRVYIHPCHLLYYS |
[Des-Arg9]-Bradykinin | RPPGFSPF |
[Des-His1,Glu9] Glucagon, amide | SQGTFTSEYSKYLDSRRAQDFVQWLMNT-NH2 |
[DPro2,DPhe7,DTrp9] Substance P | R-DPro-KPQQ-DPhe-F-DTrp-LM-NH2 |
[DTrp6]-LH-RH, amide | Glp-HWSY-DTrp-LRPG-NH2 |
[Gln8]-C517 (LH-RH), chicken | {pGLU}-HWSYGLQPG |
[Glu1] Fibrinopeptide B, human | EGVNDNEEGFFSAR |
[Leu5]-Enkephalin | YGGFL |
[Leu5]-Enkephalin, amide | YGGFL-NH2 |
[Leu8] Renin Substrate Tetradecapeptide, rat | DRVYIHPLHLLYYS |
[Met5]-Enkephalin, amide | YGGFM-NH2 |
[Nle11]-Substance P | RPKPQQFFGL-{NLE}-NH2 |
[pSer2, pSer5, pSer7]-CTD | Y-{pSer}-PT-{pSer}-P-{pSer}-YSPTSPSYSPTSPS |
[pThr3]-CDK5 Substrate | PK-{pTHR}-PKKAKKL |
[pTyr5] EGFR 988-993 | DADE-{pTyr}-L |
[Pyr1]-Apelin-13 | {Glp}-RPRLSHKGPMPF |
[Sar1, Ile8]-Angiotensin II | {SAR}-RVYIHPI |
[Sar9,Met(O2)11]-Substance P | RPKPQQFF-{Sar}-LM[O2]-NH2 |
[Sar9] Substance P | RPKPQQFF-{SAR}-LM-NH2 |
[SER140]-PLP(139-151) | HSLGKWLGHPDKF |
[Thi5,8,DPhe7] Bradykinin | RPPG-Thi-S-DPhe-Thi-R |
[Tyr0] Bradykinin | YRPPGFSPFR |
[Tyr0] Fibrinopeptide A, human | YADSGEGDFLAEGGGVR |
[Tyr38, Phe42,46] Bone Gla Protein | YQEAFRRFFGPV |
[Val8] Renin Substrate Tetradecapeptide, rat | DRVYIHPVHLLYYS |
{Val1}-Exendin-3/4 | VSKQMEEEAVRLFIEWLKNGGPSSGAPPPS |
26Rfa, Hypothalamic Peptide, human | TSGPLGNLAEELNGYSRKKGGFSFRF-NH2 |
2-Furoyl-LIGRLO-amide | {Fur-2-oyl}-LIGRL-{Orn}-NH2 |
3Flag | DYKDDDDKGDYKDDDDKIDYKDDDDK |
3X FLAG peptide | MDYKDHDGDYKDHDIDYKDDDDK |
5FAM-DEEIYEELK-NH2 | 5FAM-DEEIYEELK-NH2 |
5FAM-ERRKSKSGA-NH2 | 5FAM-ERRKSKSGA-NH2 |
5FAM-NVKSKIGSTENLK-NH2 | 5FAM-NVKSKIGSTENLK-NH2 |
5FAM-QNPSRCSVSLSNVEA-NH2 | 5FAM-QNPSRCSVSLSNVEA-NH2 |
5FAM-RKRRQTSM | 5FAM-RKRRQTSM |
5FAM-RKRSRAEA-NH2 | 5FAM-RKRSRAEA-NH2 |
5FAM-RPRTSSF | 5FAM-RPRTSSF |
5FAM-RQMSFRL | 5FAM-RQMSFRL |
5FAM-RTKRSGSVYEPLKI-NH2 | 5FAM-RTKRSGSVYEPLKI-NH2 |
5-Tamra-DRVYIHP | 5-Tamra-DRVYIHP |
Abaloparatide TFA | AVSEHQLLHDKGKSIQDLRRRELLEKLL-{Aib}-KLHTA-NH2 |
Abl Cytosolic Substrate | EAIYAAPFAKKK |
Abz-FR-K(Dnp)-P-OH | Abz-FR-K(Dnp)-P |
Ac2-26 TFA | AMVSEFLKQAWFIENEEQEYVQTVK |
Ac-DEVD-AFC | Ac-DEVD-7-amido-4-trifluoroMethylcoumarin |
Acetalin-1 | Ac-RFMWMT-NH2 |
Acetalin-2 | Ac-RFMWMR-NH2 |
Acetalin-3 | Ac-RFMWMK-NH2 |
Acetyl Angiotensinogen (1-14), porcine | Ac-DRVYIHPFHLLVYS |
Acetyl, Angiotensinogen (1-14), human | Ac-DRVYIHPFHLVIHN |
Acetyl-PHF6 amide TFA | Ac-VQIVYK-NH2 |
Ac-IEPD-AFC | Ac-IEPD-AFC |
Ac-IEVDID (TFA) | Ac-IEVDID |
Ac-IEVDIDV (TFA) | Ac-IEVDIDV |
Ac-IEVDIDVE (TFA) | Ac-IEVDIDVE |
Ac-IEVDIDVEH (TFA) | Ac-IEVDIDVEH |
Ac-Leu-Arg-AMC | Ac-Leu-Arg-AMC |
Ac-MBP 1-11 | Ac-ASQKRPSQRSK |
ACTH (1-10), human | SYSMEHFRWG |
ACTH (1-13), human | SYSMEHFRWGKPV |
ACTH (1-16), human | SYSMEHFRWGKPVGKK |
ACTH (1-17), human | SYSMEHFRWGKPVGKKR |
ACTH (1-24), human | SYSMEHFRWGKPVGKKRRPVKVYP |
ACTH (1-39), human | SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF |
ACTH (1-39), rat | SYSMEHFRWGKPVGKKRRPVKVYPNVAENESAEAFPLEF |
ACTH (18-39), human | RPVKVYPNGAEDESAEAFPLEF |
ACTH (4-10), human | MEHFRWG |
ACTH (4-11), human | MEHFRWGK |
ACTH (6-24), human | HFRWGKPVGKKRRPVKVYP |
ACTH 11-24 | KPVGKKRRPVKVYP |
ACTH 1-14 | SYSMEHFRWGKPVG |
ACTH 22-39 | VYPNGAEDESAEAFPLEF |
ACTH 34-39 | AFPLEF |
Activated Protein C (390-404), human | YGVYTKVSRYLDWIH |
Ac-VDID (TFA) | Ac-VDID |
Acyl Carrier Protein (ACP) 65-74 | VQAAIDYING |
Adipokinetic Hormone (AKH) (24-32), locust | Pyr-LNFTPNWGT-NH2 |
Adrenomedullin (1-12), human | YRQSMNNFQGLR |
Adrenomedullin (11-50), rat | STGCRFGTCTMQKLAHQIYQFTDKDKDGMAP RNKISPQGY-NH2(Disulfide bridge: Cys4-Cys9) |
Adrenomedullin (1-50), rat | YRQSMNQGSRSTGCRFGTCTMQKLAHQIYQFTDKDKDGMAPRNKISPQGY-NH2 (Disulfide bridge: Cys14-Cys19) |
Adrenomedullin (16-31), human | CRFGTCTVQKLAHQIY-NH2 |
Adrenomedullin (22-52), human | TVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 |
Adrenomedullin (AM) (13-52), human | SFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 (Disulfide bridge: Cys16-Cys21) |
Adrenomedullin (AM) (1-52), human TFA | YRQSMNNFQGLRSFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 (Disulfide bridge: Cys16-Cys21) |
AGA-(C8R) HNG17, Humanin derivative | PAGASRLLLLTGEIDLP |
a-Helical Corticotropin Releasing Factor (12-41) | FHLLREMLEMAKAEQEAEQAALNRLLLEEA-NH2 |
Alexamorelin Met 1 | {d-Mrp}-Ala-Trp-{d-Phe} |
Alisporivir intermediate-1 | DAVVLADALLV-{Aaa}-{Abu} |
Allatostatin II | GDGRLYAFGL-NH2 |
Allatostatin III | GGSLYSFGL-NH2 |
Allatostatin IV | DRLYSFGL-NH2 |
Allatostatins/Allatostatin I | APSGAQRLYGFGL-NH2 |
Allergen Gal d 4 (46-61), chicken | NTDGSTDYGILQINSR |
Alpha 1(I) Collagen (614-639), human | SAGFDFSFLPQPPQEKAHDGGRYYRA |
ALX 40-4C Trifluoroacetate | Ac-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-NH2 |
AMARA peptide | AMARAASAAALARRR |
Amylin (8-37), rat | ATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2 |
Amylin (IAPP), feline | KCNTATCATQRLANFLIRSSNNLGAILSPTNVGSNTY-NH2 (Disulfide bridge: Cys2-Cys7) |
Amylin, amide, human | KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2 (Disulfide bridge: Cys2-Cys7) |
Amylin, amide, rat | KCNTATCATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2 (Disulfide bridge: Cys2-Cys7) |
Amyloid β-peptide (1-40) rat | DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVV |
Angiogenin (108-122) TFA | ENGLPVHLDQSIFRR |
Angiopep-2 | NH2-TFFYGGSRGKRNNFKTEEY-COOH |
Angiotensin Converting Enzyme Inhibitor | Glp-WPRPQIPP |
Angiotensin I Converting Enzyme Inhibitor | RPGFSPFR |
Angiotensin I, human | DRVYIHPFHL |
Angiotensin I/II 1-5 | DRVYI |
Angiotensin I/II 1-6 | DRVYIH |
Angiotensin II (1-4), human | DRVY |
Angiotensin II (3-8), human | VYIHPF |
Angiotensin II (5-8), human | IHPF |
Angiotensin II 5-valine | DRVYVHPF |
Angiotensin II Antipeptide | EGVYVHPV |
Angiotensin II, human | DRVYIHPF |
Angiotensin III, human | RVYIHPF |
Angiotensinogen (1-13), human | DRVYIHPFHLVIH |
Angiotensinogen (1-14), human | DRVYIHPFHLVIHN |
Angiotensinogen (1-14), porcine | DRVYIHPFHLLVYS |
Antennapedia Peptide | RQIKIWFQNRRMKWKK |
Anti-Inflammatory Peptide 1 | MQMKKVLDS |
Antioxidant peptide A | PHCKRM |
Apamin | CNCKAPETALCARRCQQH-NH2 (Disulfide bridge: Cys1-Cys11;Cys3-Cys15) |
Apelin-13, human, bovine | QRPRLSHKGPMPF |
Apraglutide | HGDGSFSDEX FTILDLLAAR DFINWLIQTK ITD-NH2 |
ARA290 | {Glp}-EQLERALNSS |
Arg-Gly-Asp-Cys | RGDC |
Arg-Gly-Asp-Ser (TFA) | RGDS |
Arg-Gly-Glu-Ser | Arg-Gly-Glu-Ser |
Argipressin | CYFQNCPRG-NH2 (Disulfide bridge: Cys1-Cys6) |
Argireline | Ac-EEMQRR-NH2 |
Asp-Asp-Asp-Asp-Asp | DDDDD |
Astressin | {d-Phe}-HLLREVLE-NLE-ARAEQLAQEAHKNRKL-NLE-EII-NH2 |
ATI-2341 | 1-Oxohexadecyl-MGYQKKLRSMTDKYRL |
Atrial Natriuretic Peptide (ANP) (1-28), human, porcine Acetate | SLRRSSCFGGRMDRIGAQSGLGCNSFRY (Disulfide bridge: Cys7-Cys23) |
Atrial Natriuretic Peptide (ANP) (1-28), rat | SLRRSSCFGGRIDRIGAQSGLGCNSFRY (Disulfide bridge: Cys7-Cys23) |
Autocamtide 2 | KKALRRQETVDAL |
Autocamtide 2, amide | KKALRRQETVDAL-NH2 |
Axltide | KKSRGDYMTMQIG |
AZP-531 | Cyclo(RVQSPEHQ) |
Bacterial Sortase Substrate III, Abz/DNP | Abz-LPETG-K(Dnp)-NH2 |
Bak BH3 | GQVGRQLAIIGDDINR |
BAM-22P | YGGFMRRVGRPEWWMDYQKRYG |
BCMA72-80 | YLMFLLRKI |
BDC2.5 mimotope 1040-31 | YVRPLWVRME |
Bim BH3, Peptide IV | DMRPEIWIAQELRRIGDEFNAYYARR |
Biotinyl-Angiotensin I | Biotin-DRVYIHPFHL |
BMf-BH3 | LQHRAEVQIARKLQCIADQFHRLHT |
BNP-45 (rat) | SQDSAFRIQERLRNSKMAHSSSCFGQKIDRIGAVSRLGCDGLRLF(Disulfide bridge: Cys23-Cys39) |
Boc-Gly-Gly-Phe-Gly-OH TFA | Boc-Gly-Gly-Phe-Gly-OH TFA |
Boc-Ile-Glu-Gly-Arg-AMC | Boc-Ile-Glu-Gly-Arg-AMC |
Bombesin | {Glp}-QRLGNQWAVGHLM-NH2 |
Bombinin-Like Peptide BLP-1 | GIGASILSAGKSALKGLAKGLAEHFAN-NH2 |
Bone Gla Protein (45-49) | FYGPV |
BQ-3020 TFA | N-Acetyl-LMDKEAVYFAHLDIIW |
Bradykinin | RPPGFSPFR |
Bradykinin (1-3) | RPP |
Bradykinin (1-5) | RPPGF |
Bradykinin (1-6) | RPPGFS |
Bradykinin (1-7) | RPPGFSP |
Brain Derived Acidic Fibroblast Growth Factor (102-111) | HAEKHWFVGL |
Brain Derived Acidic Fibroblast Growth Factor (1-11) | FNLPLGNYKKP |
Brain Derived Basic Fibroblast Growth Factor (1-24) | PALPEDGGSGAFPPGHFKDPKRLY |
Brain Natriuretic Peptide (BNP) (1-32), rat | NSKMAHSSSCFGQKIDRIGAVSRLGCDGLRLF (Disulfide bridge: Cys10-Cys26) |
Buserelin Acetate | {pGlu}-HWSY-{d-S(tBu)}-LRP-NHEt |
c(RGDfC) | c(RGDfC) |
c(RGDfK) | c(RGDfK) |
c(RGDKC) | c(RGDKC) |
c(RGDyC) | c(RGDyC) |
C3a 70-77 | ASHLGLAR |
Caerulein, desulfated | Glp-QDYTGWMDF-NH2 |
Calcineurin substrate (TFA) | DLDVPIPGRFDRRVSVAAE |
Calcitonin Gene Related Peptide (CGRP) (83-119), rat | SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2 (Disulfide bridge: Cys2-Cys7) |
Calcitonin Gene Related Peptide (CGRP) II, rat | SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSKAF-NH2 (Disulfide bridge: Cys2-Cys7) |
Calcitonin salmon | CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP-NH2 (Disulfide bridge: Cys1-Cys7) |
Calcitonin, eel TFA | CSNLSTCVLGKLSQELHKLQTYPRTDVGAGTP-NH2 (Disulfide bridge: Cys1-Cys7) |
Calcitonin, human | CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2 (C1&C7 bridge) |
Calcitonin, rat | CGNLSTCMLGTYTQDLNKFHTFPQTSIGVGAP-NH2 (C1&C7 bridge) |
Calmodulin Binding Peptide 1 | GVMPREETDSKTASPWKSARLMVHTVATFNSIKELNERWRSLQQLA |
Calmodulin-Dependent Protein Kinase II (290-309) | LKKFNARRKLKGAILTTMLA |
Calmodulin-Dependent Protein Kinase II 281-309 | MHRQETVDCLKKFNARRKLKGAILTTMLA |
cAMP Dependent PK Inhibitor (5-22), amide | TTYADFIASGRTGRRNAI-NH2 |
Carcinoembryonic Antigen CEA | YLSGANLNL |
Cardiotoxin Analog (CTX) IV (6-12) (TFA) | LIPPFWK-NH2 |
CART (55-76), rat | IPIYEKKYGQVPMCDAGEQCAV(Cys14&Cys20 bridge) |
Casein Kinase II Substrate | RRREEETEEE |
Casein Kinase Substrates 3 | RRKDLHDDEEDEAMSITA |
CD36 Peptide P (139-155) | CNLAVAAASHIYQNQFVQ |
CD36 Peptide P (93-110) | YRVRFLAKENVTQDAEDNC |
CDK2 | HHASPRK |
Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK-NH2 |
Cecropin A-melittin hybrid peptide [CA(1-7)M(2-9)NH2] | KWKLFKKIGAVLKVL-NH2 |
Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL-NH2 |
Cecropin P1, porcine | SWLSKTAKKLENSAKKRISEGIAIAIQGGPR |
CEF1, Influenza Matrix Protein M1 58-66 | GILGFVFTL |
CEF14, EBV Rta Protein 28-37 | DYCNVLNKEF |
CEF19, Epstein-Barr Virus latent NA-3A 458-466 | YPLHEQHGM |
CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156 | RVRAYTYSK |
CEF3 | SIIPSGPLK |
CEF4 | RVLSFIKGTK |
CEF6 | LPFDKTTVM |
CEF7, Influenza Virus NP 380-388 | ELRSRYWAI |
CEF8, Influenza Virus NP 383-391 | SRYWAIRTR |
Ceratotoxin A | SIGSALKKALPVAKKIGKIALPIAKAALP |
Ceratotoxin B | SIGSAFKKALPVAKKIGKAALPIAKAALP |
Cerebellin | SGSAKVAFSAIRSTNH |
CH 5450 | Z-Ile-Glu-Pro-Phe-Ome |
Chemerin-9 149-157 | YFPGQFAFS |
Chlorotoxin(linear) | MCMPCFTTDHQMARKCDDCCGGKGRGKCYGPQCLCR-NH2 |
Cholecystokinin, CCK Octapeptide (26-33), Non-Sulfated form | DYMGWMDF-NH2 |
Cholecystokinin, CCK Tetrapeptide (30-33) | WMDF-NH2 |
Chromostatin, bovine | SDEDSDGDRPQASPGLGPGP |
CLIP 86-100 | PVSKMRMATPLLMQA |
c-Myc Peptide Trifluoroacetate | EQKLISEEDL |
Colivelin | SALLRSIPAPAGASRLLLLTGEIDLP |
Collagen Binding Fragment | CQDSETRTFY |
Competence-Stimulating Peptide-12261 | EIRQTHNIFFNFFKRR |
Compstatin | ICVVQDWGHHRCT-NH2 (Disulfide bridge: Cys2-Cys12) |
Conopressin S | CIIRNCPRG-NH2 (Disulfide bridge: Cys1-Cys6) |
Corazonin | Glp-TFQYSRGWTN-NH2 |
Corticotropin-releasing factor human | SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII-NH2 |
Cortistatin 14, human, rat | PCKNFFWKTFSSCK (Disulfide bridge: Cys2-Cys13) |
Cortistatin 29 (1-13) | Glp-ERPPLQQPPHRD |
Cortistatin-14 | PCKNFFWKTFSSCK-NH2 (Disulfide bridge: Cys2-Cys13) |
C-Peptide, dog | EVEDLQVRDVELAGAPGEGGLQPLALEGALQ |
C-Reactive Protein (CRP) 174-185 | IYLGGPFSPNVL |
C-Reactive Protein (CRP) 201-206 | KPQLWP |
C-Reactive Protein (CRP) 77-82 | VGGSEI |
CREBtide | KRREILSRRPSYR |
CRF, bovine | SQEPPISLDLTFHLLREVLEMTKADQLAQQAHNNRKLLDIA-NH2 |
Crustacean Cardioactive Peptide CCAP | PFCNAFTGC |
C-telopeptide | EKAHDGGR |
CTTHWGFTLC, CYCLIC | CTTHWGFTLC (Disulfide Bridge: Cys1-Cys10) |
C-Type Natriuretic Peptide (1-53), human | DLRVDTKSRAAWARLLQEHPNARKYKGANKKGLSKGCFGLKLDRIGSMSGLGC |
C-Type Natriuretic Peptide (CNP) (1-22), human | GLSKGCFGLKLDRIGSMSGLGC (Disulfide bridge: Cys6-Cys22) |
Cyclic MKEY | CKEYFYTSSKSSNLAVVFVTRC |
Cyclic somatostatin | HAGCKNFFWKTFTSC-OH (Disulfide bridge: Cys3-Cys14) |
Cyclo(Phe-Pro) | Cyclo(Phe-Pro) |
Cyclo(RADfK) | Cyclo(Ala-Asp-Phe-Lys-Arg) |
Cyclo(RGDyK) | Cyclo(RGDyK) |
Cyclosporin A-Derivative 1 | LVLADALLV-{Aaa}-{Abu}-{Sar} |
Cyclosporin A-Derivative 2 | VLADALLV-{Aaa}-{Abu}-{Sar} |
CYN 154806 | Ac-FCYWKTCY-NH2 (Disulfide bridge: Cys2-Cys7) |
CysHHC10 TFA | CKRWWKWIRW-NH2 |
Cys-TAT(47-57) | CYGRKKRRQRRR-NH2 |
DAMGO | Y-{d-Ala}-G-{Me-Phe}-G-ol |
DAPTA | ASTTTNYT-NH2 |
Delta-Sleep Inducing Peptide | WAGGDASGE |
Dermaseptin | ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ |
Dermorphin Analog | Y-{d-Arg}-F-{SAR}-YPS-NH2 |
Diazepam-Binding Inhibitor Fragment, human | QATVGDINTERPGMLDFTGK |
Difopein TFA | SADGAPHCVPRDLSWLDLEANMCLPGAAGLDSADGAPHCVPRDLSWLDLEANMCLPGAAGLE |
D-Lys(Z)-Pro-Arg-pNA | {d-Lys(Z)}-PR-pNA |
D-Lys(Z)-Pro-Arg-pNA diacetate | {d-Lys(Z)}-P-R-pNA |
Dynorphin (2-17), amide, porcine | GGFLRRIRPKLKWDNQ-NH2 |
Dynorphin A (1-13), amide, porcine | YGGFLRRIRPKLK-NH2 |
Dynorphin A (1-13), porcine | YGGFLRRIRPKLK |
Dynorphin A (1-17) | YGGFLRRIRPKLKWDNQ |
Dynorphin A (2-17), porcine | GGFLRRIRPKLKWDNQ |
Dynorphin A 1-10 | YGGFLRRIRP |
Dynorphin A amide, porcine | YGGFLRRIRPKLKWDNQ-NH2 |
Dynorphin B (1-13) | YGGFLRRQFKVVT |
Dynorphin B (1-9) | YGGFLRRQF |
EGF Receptor Substrate 2 Phospho-Tyr5 | HDADE-{pTyr}-LIPQQG-OH |
EGFRvIII peptide PEPvIII | LEEKKGNYVVTDHC |
Egg Laying Hormone, aplysia | ISINQDLKAITDMLLTEQIRERQRYLADLRQRLLEK-NH2 |
Elamipretide | {d-Arg}-Dmt-KF-NH2 |
Eledoisin | {Glp}-PSKDAFIGLM-NH2 |
Eledoisin Related Peptide | KFIGLM-NH2 |
Endothelin-2, human | CSCSSWLDKECVYFCHLDIIW (Disulfide bridge: Cys1-Cys15, Cys3-Cys11) |
Endothelin-3, human, mouse, rabbit, rat | CTCFTYKDKECVYYCHLDIIW(Disulfide bridge: Cys1-Cys15, Cys3-Cys11) |
Enfuvirtide | Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2 |
Enterostatin, human, mouse, rat | APGPR |
Epidermal Growth Factor Receptor Peptide (985-996) | DVVDADEYLIPQ |
Epithalon TFA | AEDG |
Etelcalcetide hydrochloride | C'-Ac-d-C-d-A-d-R-d-R-d-R-d-A-d-R-NH2 (Disulfide bridge: Cys1'-Cys1) |
EXENDIN (9-39) | DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
Exendin derivative 1 | HAEGTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPSLMNPQRSTVWY |
Exendin-3 | HSDGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
Exendin-3/4 (59-86) | KQMEEEAVRLFIEWLKNGGPSSGAPPPS |
Exendin-3/4 (64-86) | EAVRLFIEWLKNGGPSSGAPPPS |
Exendin-4 | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
Fam-Bradykinin | 5FAM-RPPGFSPFR |
Fertirelin | {Glp}-HWSYGLRP |
FFAGLDD | FFAGLDD |
FHV Coat-(35–49) | RRRRNRTRRNRRRVR |
Fibrinogen Binding Inhibitor Peptide | HHLGGAKQAGDV |
Fibrinogen-Binding Peptide | EHIPA |
Fibrinopeptide A, human | ADSGEGDFLAEGGGVR |
Fibrinopeptide B, human | {Glp}-GVNDNEEGFFSAR |
Fibronectin Active Fragment Control | GRGES |
Fibronectin Adhesion-promoting Peptide | WQPPRARI |
Fibronectin CS1 Peptide | EILDVPST |
Flag Peptide | DYKDDDDK |
Flagelin 22(TFA) | QRLSTGSRINSAKDDAAGLQIA |
FliC, Serotype a (427-441), S.paratyphi A | VQNRFNSAITNLGNT |
Fmoc-N-Me-Ala-OH | Fmoc-N-Me-Ala-OH |
Fmoc-N-Me-Leu-OH | Fmoc-N-Me-Leu-OH |
Fmoc-N-Me-Phe-OH | Fmoc-N-Me-Phe-OH |
Fmoc-Val-Cit-PAB-PNP | Fmoc-V-Cit-PAB-PNP |
FMRF | FMRF |
FMRF-amide | FMRF-NH2 |
Foxy-5 | MDGCEL |
G280-9 | YLEPGPVTA |
Galanin (1-16), mouse, porcine, rat TFA | GWTLNSAGYLLGPHAI |
Galanin (1-19), human | GWTLNSAGYLLGPHAVGNH |
Galanin, human | GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS |
Galanin, rat | GWTLNSAGYLLGPHAIDNHRSFSDKHGLT-NH2 |
Galantide | GWTLNSAGYLLGPQQFFGLM-NH2 |
Gap26 | VCYDKSFPISHVR |
GAP27 | SRPTEKTIFII |
Gastrin 1, human | Pyr-GPWLEEEEEAYGWMDF-CONH2 |
Gastrin I (1-14), human | Glp-GPWLEEEEEAYGW |
Gastrin-Releasing Peptide, human | VPLPAGGGTVLTKMYPRGNHWAVGHLM-NH2 |
GHRF (1-29), amide, human | YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 |
GHRF (1-29), amide, rat | HADAIFTSSYRRILGQLYARKLLHEIMNR-NH2 |
GIP (1-30) amide (Human) | YAEGTFISDYSIAMDKIHQQDFVNWLLAQK-NH2 |
GLGPNPCRKKCYKRDFLGR | GLGPNPCRKKCYKRDFLGR |
GLP-1 (7-36), amide, chicken, common turkey | HAEGTYTSDITSYLEGQAAKEFIAWLVNGR-NH2 |
GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG |
GLP-1 moiety from Dulaglutide | HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGG |
GLP-1(7-36) Acetate | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRNH2 |
GLP-1(7-37) | HAEGTFTSDVSSYLEGQAAKEFIAWLVKG-R-G |
GLP-1/Glucagon-Like Peptide, amide, human | HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
GLP-1/Glucagon-Like Peptide, human | HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG |
GLP-2, human | HADGSFSDEMNTILDNLAARDFINWLIQTKITD |
Glucagon (19-29), human | AQDFVQWLMNT |
Glucagon, human | HSQGTFTSDYSKYLDSRRAQDFVQWLMNT |
Glucagon-Like Peptide II, human | HADGSFSDEMNTILDNLAARDFINWLIQTKITDR |
Glucagon-Like Peptide II, rat | HADGSFSDEMNTILDNLATRDFINWLIQTKITD |
Gluten Exorphin B5 | YGGWL |
Gluten Exorphin C | YPISL |
Gly6 | GGGGGG |
Gly-Arg-Gly-Asp-Ser | GRGDS |
Glycoprotein 276-286 | SGVENPGGYCL |
Gly-Phe-Arg | GFR |
GnRH-I | Pyr-HWSYGLRPG-NH2 |
GP(33-41) | KAVYNFATC |
Gp100 (25-33), human | KVPRNQDWL |
Gp100 619-627 | RLMKQDFSV |
GPRP acetate | GPRP |
G-R-G-D-S-P | GRGDSP |
GRGDSPC | GRGDSPC |
GRGDSPK | GRGDSPK |
GroES mobile loop | ETKSAGGIVLTGS |
GsMTx4 | GCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSF |
GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS | GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS |
GTP-Binding Protein Fragment, Gs alpha | CKQLQKDKQVYRATHR |
HA Peptide | YPYDVPDYA |
HAE | His-Ala-Glu |
HAEGT | HAEGT |
HAEGTFTSD | HAEGTFTSD |
HAEGTFTSDVS | HAEGTFTSDVS |
HAEGTFTSDVSSYLE | HAEGTFTSDVSSYLE |
H-Ala-Ala-Tyr-OH | H-Ala-Ala-Tyr-OH |
Handle region peptide, rat | RILLKKMPSV |
HCGRP-(8-37) | VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF |
Hemoglobin (Hb) (64-76) | GKKVITAFNEGLK |
Hemokinin 1 (mouse) | RSRTRQFYGLM-NH2 |
Hemorphin-7 | YPWTQRF |
Hepatitis B Virus Core 128-140 | TPPAYRPPNAPIL |
HER2/neu (654-662) GP2 | IISAVVGIL |
HEX3 | KYSPSNVKI |
Hexa His | HHHHHH |
H-Gly-Gly-Pro-OH | H-Gly-Gly-Pro-OH |
H-Gly-Pro-OH | H-Gly-Pro-OH |
HIF-1 alpha 556-574 | DLDLEMLAPYIPMDDDFQL |
H-Ile-Pro-Pro-OH | Ile-Pro-Pro |
His-[D-2-ME-Trp]-Ala | His-{d-2-Me-Trp}-Ala |
His-Pro | His-Pro |
His-Pro hydrochloride | His-Pro hydrochloride |
Histatin 5 | DSHAKRHHGYKRKFHEKHHSHRGY |
Histone H1-derived Peptide | GGGPATPKKAKKL |
Histone H4 (2-21) | SGRGKGGKGLGKGGAKRHRK |
HIV (gp120) Fragment (318-327) | RGPGRAFVTI |
HIV (gp41) Fragment | AVGIGA |
HIV gag peptide 197-205 | AMQMLKETI |
HIV p17 Gag 77-85 | SLYNTVATL |
HIV-1 env Protein gp41 (1-23) amide (isolates BRU/JRCSF) | AVGIGALFLGFLGAAGSTMGARS-NH2 |
HIV-1 gag Protein p24 (194-210) | ANPDCKTILKALGPAAT |
HIV-1 Rev 34-50 | TRQARRNRRRRWRERQR |
HIV-1 TAT 48-60 | GRKKRRQRRRPPQ |
HIV-1 tat Protein (1-9) | MDPVDPNIE |
HIV-1 tat Protein (49-57) | RKKRRQRRR |
HIV-1 TAT Protein Peptide | NH2-YGRKKRRQRRR-COOH |
HPV16 E7 86-93 | TLGIVCPI |
HPV16-E711-20 epitope | YMLDLQPETT |
Hsp70-derived octapeptide | GPTIEEVD |
HSV-gB2 498-505 | SSIEFARL |
Human CMV pp65 (495-503) | NLVPMVATV |
Human growth hormone-releasing factor | YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2 |
Human Papillomavirus (HPV) E7 protein 49-57 | RAHYNIVTF |
H-Val-Pro-Pro-OH | H-Val-Pro-Pro-OH |
Hypercalcemia Malignancy Factor (1-34), amide, human | AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2 |
Hypercalcemia Malignancy Factor (1-34), human | AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA |
IFN-α Receptor Recognition Peptide 1 | CLKDRHD |
IGF-I (24-41) TFA | YFNKPTGYGSSSRRAPQT |
IGF-I (30-41) TFA | GYGSSSRRAPQT |
IKKγ NBD Inhibitory Peptide | DRQIKIWFQNRRMKWKKTALDWSWLQTE |
Ile-Thr-Asp-Gln-Val-Pro-Phe-Ser-Val | ITDQVPFSV |
Indolicidin | ILPWKWPWWPWRR-NH2 |
Influenza A NP(366-374) Strain A/PR/8/35 | ASNENMETM |
Influenza HA 126-138 | HNTNGVTAASSHE |
Influenza HA 307-319 | PKYVKQNTLKLAT |
Influenza HA 518-526 | IYSTVASSL |
Influenza NP 147-155 | TYQRTRALV |
Insulin alpha-chain 1-13 | KRGIVEQCCTSICSL |
Insulin B (9 - 23) | SHLVEALYLVCGERG |
Interleukin (IL)-6 Receptor | TSLPVQDSSSVP |
Interphotoreceptor Retinoid Binding Protein Fragment IRBP | SGIPYIISYLHPGNTILHVD |
Interphotoreceptor retinoid-binding protein(668-687) | LAQGAYRTAVDLESLASQLT |
IRBP (1-20), human | GPTHLFQPSLVLDMAKVLLD |
iRGD | c(CRGDKGPDC) |
IRL-1620 TFA | Suc-DEEAVYFAHLDIIW |
IRL-1720 | Ac-DKEAVYFAHLDIIW |
Iα52 | ASFEAQGALANIAVDKA |
JAG-1, scrambled | RCGPDCFDNYGRYKYCF |
Jagged-1 188-204 | CDDYYYGFGCNKFCRPR |
Kassinin | DVPKSDQFVGLM-NH2 |
Katacalcin | DMSSDLERDHRPHVSMPQNAN |
Kemptide | LRRASLG |
Kemptide Phospho-Ser5 | LRRA-{pSer}-LG |
Kinetensin | IARRHPYFL |
Kisspeptin-10, human (TFA) | YNWNSFGLRF-NH2 |
Kisspeptin-10, rat | YNWNSFGLRY-NH2 |
KKI-5 | Ac-PFRSVQ-NH2 |
Kv3, Channel Containing Protein 567-585 | CKESPVIAKYMPTEAVRVT |
L-Leucyl-L-alanine | L-Leucyl-L-alanine |
Lactoferricin, bovine, (BLFC) | RRWQWRMKKLG |
Lactoferrin (17-41) TFA | FKCRRWQWRMKKLGAPSITCVRRAF (Disulfide bridge: Cys3-Cys20) |
LAH4 | KKALLALALHHLAHLALHLALALKKA |
Laminin (925-933) | CDPGYIGSR |
Laminin (929-933) | YIGSR |
Laminin A Chain (2091-2108) | CSRARKQAASIKVAVSADR |
Laminin Penta Peptide, amide | YIGSR-NH2 |
LCMV gp33-41 | KAVYNFATM |
Lecirelin | {Glp}-HWSYVLRP |
LEP(116-130)(mouse) | SCSLPQTSGLQKPES-NH2 |
Leptin (116-130), mouse | SCSLPQTSGLQKPES |
Leptin (22-56), human | VPIQKVQDDTKTLIKTIVTRINDISHTQSVSSKQK |
Leptin (93-105), human | NVIQISNDLENLR |
Leucokinin I | DPAFNSWG |
Leucokinin VIII | GASFYSWG-NH2 |
LGnRH-III, lamprey | {pGLP}-HWSHDWKPG-NH2 |
LH-RH, Free Acid | Glp-HWSYGLRPG |
LH-RH, human, Gonadoreline | Glp-HWSYGLRPG-NH2 |
LH-RH, lamprey | Glp-HYSLEWKPG-NH2 |
LH-RH, salmon | Glp-HWSYGWLPG-NH2 |
Lixisenatide | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK-NH2 |
L-JNKI-1 | DQSRPVQPFLNLTTPRKPRPPRRRQRRKKRG-NH2 |
LL-37 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES |
LL-37 scrambled peptide | GLKLRFEFSKIKGEFLKTPEVRFRDIKLKDNRISVQR |
LL-37, acetylated,amidated | Ac-LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES-NH2 |
LSKL, Inhibitor of Thrombospondin TSP-1 | LSKL |
LTX-315 | KKWWKKW-Dip-K-NH2 |
Luteinizing Hormone Releasing Hormone (LH-RH), human | {Glp}-HWSYGLRPG-NH2 |
Lysozyme | RVVRDPQGIRAWVAWRNR |
M-2420 | Methoxycoumarin-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys-dinitrophenyl |
M35 | GWTLNSAGYLLGPPPGFSPFR-NH2 |
M40 | GWTLNSAGYLLGPPPALALA-NH2 |
Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS |
Magainin I | GIGKFLHSAGKFGKAFVGEIMKS |
Magainin Spacer Peptide | DAEAVGPEAFADQDLDEREVR |
Mage-1 Antigen (161-169), human | EADPTGHSY |
MAGE-3 Antigen (167-176), human | MEVDPIGHLY |
MAGE-3 Antigen (271-279), human | FLWGPRALV |
MAGE-A3 195-203 | IMPKAGLLI |
Malantide | RTKRSGSVYEPLKI |
MARCKS Peptide(151-175), Phosphorylated | KKKKKRF-{pSer}-FKK-{pSer}-FKLSGF-{pSer}-FKKNKK |
MARK Substrate | NVKSKIGSTENLK |
MART-1 (26-35) human | EAAGIGILTV |
Mas7 | INLKALAALAKALL-NH2 |
Mast cell degranulating peptide (28-49) | IKCNCKRHVIKPHICRKICGKN-NH2 |
Mast Cell Degranulating Peptide HR-1 | INLKAIAALVKKVL-NH2 |
Mast Cell Degranulating Peptide HR-2 | FLPLILGKLVKGLL-NH2 |
Mastoparan | INLKALAALAKKIL-NH2 |
Mastoparan X | INWKGIAAMAKKLL-NH2 |
MCA-SEVNLDAEFR-K(Dnp)-RR, amide | MCA-SEVNLDAEFR-K(Dnp)-RR-NH2 |
Melanin Concentrating Hormone, salmon | DTMRCMVGRVYRPCWEV (Disulfide bridge: Cys5-Cys14) |
Melanocyte-Stimulating Hormone-Release Inhibiting Factor | PLG-NH2 |
Melittin | GIGAVLKVLTTGLPALISWIKRKRQQ-NH2 |
Men 10376 | DY-DTrp-V-DTrp-DTrp-K-NH2 |
Men 10376 TFA | Asp-Tyr-{d-Trp}-Val-{d-Trp}-{d-Trp}-Lys-NH2 |
Met-Enkephalin | YGGFM |
MG-132 | RPKPQQFFGLM-NH2 |
Microtubule-associated protein tau (26-44) | QGGYTMHQDQEGDTDAGLK |
Mini Gastrin I, human | LEEEEEAYGWMDF-NH2 |
MOG 35-55 | MEVGWYRSPFSRVVHLYRNGK |
Moth Cytochrome C (MCC) 88-103 | ANERADLIAYLKQATK |
Motilin, canine | FVPIFTHSELQKIREKERNKGQ |
Motilin, human, porcine | FVPIFTYGELQRMQEKERNKGQ |
MPG, HIV related | GALFLGFLGAAGSTMGAWSQPKSKRKV |
mTRP-2 180-188 | SVYDFFVWL |
MUC5AC motif peptide | GTTPSPVPTTSTTSAP |
Murepavadin TFA | Cyclo(AS-{d-Pro}-PTWI-{Dab}-{Orn}-{d-Dab}-{Dab}-W-{Dab}-{Dab}) |
Myelin Basic Protein (68-84), guinea pig | YGSLPQKSQRSQDEN |
Myelin Basic Protein (87-99) (human, bovine, rat) | VHFFKNIVTPRTP |
Myelopeptide-2 (MP-2) | LVVYPW |
Myomodulin | PMSMLRL-NH2 |
Myosin Kinase Inhibiting Peptide | KKRAARATS-NH2 |
N-Acetyl, ACTH (1-17), human | Ac-SYSMEHFRWGKPVGKKR |
N-Acetyl-Ser-Asp-Lys-Pro | Ac-SDKP |
N-Acetyl-α-Endorphin | Ac-YGGFMTSEKSQTPLVT |
N-Boc-Phe-Leu-Phe-Leu-Phe | N-Boc-Phe-Leu-Phe-Leu-Phe |
N-CBZ-Phe-Arg-AMC | CBZ-FR-AMC |
Nesiritide | SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH (Disulfide bridge: Cys10-Cys26) |
Neurokinin A / Substance K | HKTDSFVGLM-NH2 |
Neurokinin A(4-10) | DSFVGLM-NH2 |
Neurokinin B | DMHDFFVGLM-NH2 |
Neuromedin (U25), human | FRVDEEFQSPFASQSRGYFLFRPRN-NH2 |
Neuromedin B | GNLWATGHFM-NH2 |
Neuromedin C | GNHWAVGHLM-NH2 |
Neuromedin N | KIPYIL |
Neuromedin U, rat | YKVNEYQGPVAPSGGFFLFRPRN-NH2 |
Neuronostatin-13 human | LRQFLQKSLAAAA-NH2 |
Neuropeptide AF (93-110), Human | AGEGLNSQFWSLAAPQRF-NH2 |
Neuropeptide EI, rat | EIGDEENSAKFPI-NH2 |
Neuropeptide FF | FLFQPQRF-NH2 |
Neuropeptide K, porcine | DADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLM-NH2 |
Neuropeptide W-23(human) | WYKHVASPRYHTVGRAAGLMGL |
Neuropeptide Y (13-36), human | PAEDMARYYSALRHYINLITRQRY-NH2 |
Neuropeptide Y (22-36) | SALRHYINLITRQRY-NH2 |
Neuropeptide Y(29-64) | YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY |
Neuropeptide Y, human | YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 |
Neurotensin | Pyr-LYENKPRRPYIL |
Neurotensin (8-13) | RRPYIL |
NFAT Inhibitor | MAGPHPVIVITGPHEE |
N-Formyl-Met-Ala-Ser | Formyl-MAS |
N-Formyl-Met-Leu-Phe | Formyl-MLF |
N-Formyl-Met-Leu-Phe-Lys | Formyl-MLFK |
N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys | N-Formyl-{NLE}-LF-{NLE}-YK |
NGR peptide Trifluoroacetate | CNGRCG |
NH2-KLGADTDGEQDQHMTYGGQ-COOH | KLGADTDGEQDQHMTYGGQ |
NLS PKKKRKV | PKKKRKV |
Nociceptin (1-13), amide | FGGFTGARKSARK-NH2 |
Nociceptin / Orphanin FQ | FGGFTGARKSARKLANQ |
Nocistatin | EQKQLQ |
NT 13 | TPPT |
NTB (Naltriben) | DPhe-CY-DTrp-Orn-T-Pen-T-NH2(Cys2&Pen7 bridge) |
N-terminally acetylated Endomorphin-1 | Ac-LYLPLWLF-NH2 |
N-terminally acetylated Leu-enkephalin | Ac-LYGGLFDL-COOH |
Nuclear pore complex protein Nup98 315-360 | Ac-MGLFGVTQASQPGGLFGTATNTSTGTAFGTGTGLFGQTNTGFGAV |
Nucleoprotein 118-126 | RPQASGVYM |
Nucleoprotein 396-404 | FQPQNGQFI |
NY-BR-1 p904 A2 | SLSKILDTV |
Obestatin (human) | FNAPFDVGIKLSGVQYQQHSQAL-NH2 |
Octreotide | FCFWKTCT (Disulfide bridge: Cys2-Cys7) |
Orexin B, canine | RPGPPGLQGRLQRLLQASGNHAAGILTM-NH2 |
Orexin B, human | RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2 |
Orexin B, rat, mouse | RPGPPGLQGRLQRLLQANGNHAAGILTM-NH2 |
Ornipressin | CYFQNCP-{Orn}-G-NH2 (Disulfide bridge: Cys1-Cys6) |
Osteocalcin (37-49), human | GFQEAYRRFYGPV |
Osteogenic Growth Peptide, OGP | ALKRQGRTLYGFGG |
OV-1, sheep | KNLRRIIRKIIHIIKKYG |
OVA 323-339 | ISQAVHAAHAEINEAGR |
OVA G4 peptide | SIIGFEKL |
OVA peptide (257-264) | SIINFEKL |
OVA sequence 323-336 | ISQAVHAAHAEINE |
p2Ca | LSPFPFDL |
P34cdc2 Kinase Substrate Peptide | ADAQHATPPKKKRKVEDPKDF |
p5 Ligand for Dnak and DnaJ | CLLLSAPRR |
p53 17-26 | ETFSDLWKLL |
PA (224-233), Influenza | SSLENFRAYV |
PACAP (1-27), human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2 |
PACAP (1-38), human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 |
PACAP (6-27), human, ovine, rat | FTDSYSRYRKQMAVKKYLAAVL-NH2 |
PACAP (6-38), human, ovine, rat | FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 |
PACAP-38 (16-38), human, mouse, rat | QMAVKKYLAAVLGKRYKQRVKNK-NH2 |
PACAP-38 (31-38), human, mouse, rat | YKQRVKNK-NH2 |
PACAP-Related Peptide (PRP), human | DVAHGILNEAYRKVLDQLSAGKHLQSLVA |
PACAP-Related Peptide (PRP), rat | DVAHEILNEAYRKVLDQLSARKYLQSMVA |
Palmitoyl Tetrapeptide-3 | Palm-GQPR |
Pancreatic Polypeptide (human) | APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2 |
Pancreatic Polypeptide (rat) | APLEPMYPGDYATHEQRAQYETQLRRYINTLTRPRY-NH2 |
Pancreatic Polypeptide, bovine | APLEPEYPGDNATPEQMAQYAAELRRYINMLTRPRY-NH2 |
PAR - 1 Agonist;Protease - Activated Receptor - 1 | TFLLRN |
PAR-4 (1-6) (human) | GYPGQV |
PAR-4 (1-6) (mouse) | GYPGKF |
PAR-4 (1-6) amide (human) | GYPGQV-NH2 |
PAR-4 (1-6) amide (mouse) | GYPGKF-NH2 |
PAR-4 Agonist Peptide, amide | AYPGKF-NH2 |
Parasin I (TFA) | KGRGKQGGKVRAKAKTRSS |
Parathyroid Hormone (1-34), bovine | AVSEIQFMHNLGKHLSSMERVEWLRKKLQDVHNF |
Parathyroid Hormone (1-34), rat | AVSEIQLMHNLGKHLASVERMQWLRKKLQDVHNF |
Pep-1 | KETWWETWWTEWSQPKKKRKV |
Peptide 401 | IKCNCKRHVIKPHICRKICGKN-NH2 (Disulfide bridge: Cys3-Cys15, Cys5-Cys19) |
Peptide C105Y | CSIPPEVKFNKPFVYLI |
Peptide M | DTNLASSTIIKEGIDKTV |
Peptide T | ASTTTNYT |
Peptide YY (PYY) (3-36), human | IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY-NH2 |
Peptide YY (PYY), human | YPIKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY-NH2 |
PGLa | GMASKAGAIAGKIAKVALKAL-NH2 |
pGlu-Pro-Arg-MNA | {pGlu}-PR-MNA |
pGlu-Pro-Arg-MNA monoacetate | {pGlu}-Pro-Arg-MNA |
Phe-Met-Arg-Phe Like Peptide | {pGLU}-DPFLRF |
PHI, rat | HADGVFTSDYSRLLGQISAKKYLESLI-NH2 |
Phosphate Acceptor Peptide | RRKASGPPV |
Phosphorylase Kinase b-Subunit (420-436) | KRNPGSQKRFPSNCGRD |
P-H-P-F-H-F-F-V-Y-K | PHPFHFFVYK |
Phyllomedusin | Glp-NPNRFIGLM-NH2 |
Physalaemin | Glp-ADPNKFYGLM-NH2 |
Piscidin-1 (22-42) | GFIFHIIKGLFHAGKMIHGLV-NH2 |
PKG Substrate | RKRSRAE |
Platelet Factor 4 (58-70), human | PLYKKIIKKLLES |
PLP 139-151 | HCLGKWLGHPDKF |
PN: US20040072744 SEQID: 2 claimed protein | NLGEHPVCDS |
Prepro VIP (111-122), human | VSSNISEDPVPV |
Prepro VIP (81-122), human | HADGVFTSDFSKLLGQLSAKKYLESLMGKRVSSNISEDPVPV |
Pressinoic Acid | CYFQNC (Disulfide bridge: Cys1-Cys6) |
Proadrenomedullin (45-92), human | ELRMSSSYPTGLADVKAGPAQTLIRPQDMKGASRSPEDSSPDAARIRV |
Pro-Adrenomedullin (N-20), human | ARLDVASEFRKKWNKWALSR-NH2 |
Pro-Adrenomedullin (N-20), porcine | ARLDVAAEFRKKWNKWALSR-NH2 |
Pro-Adrenomedullin (N-20), rat | ARLDTSSQFRKKWNKWALSR-NH2 |
Proctolin | RYLPT |
Proinsulin C-Peptide (55-89), ?human | RREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKR |
Proinsulin C-peptide human | EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ |
Prolactin Releasing Peptide (12-31), human | TPDINPAWYASRGIRPVGRF-NH2 |
Prolactin Releasing Peptide (1-31), human | SRTHRHSMEIRTPDINPAWYASRGIRPVGRF-NH2 |
Prolylleucine | Z-Pro-{d-Leu} |
Protease-Activated Receptor-2 Activating Peptide | SLIGRL-NH2 |
Protease-Activated Receptor-2, PAR-2 Agonist, amide | SLIGKV-NH2 |
Protein Kinase C (19-35) Peptide | RFARKGALRQKNVHEVK |
Protein Kinase C (gamma) Peptide | NYPLELYERVRTGC |
Protein Kinase C 19-31 | RFARKGALRQKNV |
Protein Kinase C 19-36 | RFARKGALRQKNVHEVKN |
Protein Kinase C Peptide Substrate | ERMRPRKRQGSVRRRV |
Protirelin Acetate | {pGlu}-HP-NH2 |
PrP 106-126 | KTNMKHMAGAAAAGAVVGGLG |
PSA1 141-150 | FLTPKKLQCV |
PTD-p65-P1 Peptide | DRQIKIWFQNRRMKWKKQLRRPSDRELSE |
PUMA BH3 | EEQWAREIGAQLRRMADDLNAQYER |
QKRPSQRSKYL | QKRPSQRSKYL |
QL9 | QLSPFPFDL |
R15K, HIV-1 Inhibitory Peptide | RIQRGPGRAFVTIGK |
Rabies Virus Glycoprotein (RVG29) | YTIWMPENPRPGTPCDIFTNSRGKRASNG |
Rat CGRP-(8-37) | VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2 |
RC-160 (Vapreotide) | fCYwKVCW-NH2 (C2&C7 bridge) |
RC-3095 | XQWAVGHLL-NH2 |
RC-3095 (TFA) | Xaa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2 |
ReACp53 | HRRRRRRRRRRPILTRITLE-OH |
Renin Substrate Tetradecapeptide, rat | DRVYIHPFHLLYYS |
RGD | RGD |
RGD peptide GRGDNP | GRGDNP |
RGDS | Arg-Gly-Glu-Ser(TFA) |
rGHRH(1-29)NH2 | HADAIFTSSYRRILGQLYARKLLHEIMNR |
Rhodopsin Epitope Tag | TETSQVAPA |
Risuteganib | GRG-{Cya}-TP |
RNAIII-inhibiting peptide(TFA) | YSPWTNF |
RREEETEEE | RREEETEEE |
RR-SRC | RRLIEDAEYAARG |
Rusalatide acetate | AGYKPDEGKR GDACEGDSGG PFV-NH2 |
S Tag Peptide | KETAAAKFERQHMDS |
S6-1 | RRLSSLRA |
S961 | GSLDESFYDWFERQLGGGSGGSSLEEEWAQIQCEVWGRGCPSY (Disulfide bridge: Cys33-Cys40) |
Sakamototide substrate peptide TFA | ALNRTSSDSALHRRR |
SAMS | HMRSAMSGLHLVKRR-NH2 |
Scrambled TRAP Fragment | FSLLRN-NH2 |
Scyliorhinin II | SPSNSKCPDGPDCFVGLM-NH2 |
SDV-Exendin-3/4 | SDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS |
SEB Domain 144-153 | KKKVTAQELD |
Secretin (5-27), porcine | TFTSELSRLRDSARLQRLLQGLV-NH2 |
Secretin, canine | HSDGTFTSELSRLRESARLQRLLQGLV-NH2 |
Secretin, human | HSDGTFTSELSRLREGARLQRLLQGLV-NH2 |
Secretin, porcine | HSDGTFTSELSRLRDSARLQRLLQGLV-NH2 |
Secretin, rat | HSDGTFTSELSRLQDSARLQRLLQGLV-NH2 |
Secretoneurin, rat | TNEIVEEQYTPQSLATLESVFQELGKLTGPSNQ |
Selank | TKPRPGP |
Ser25] Protein Kinase C (19-31) | RFARKGSLRQKNV |
sgp91 ds-tat Peptide 2, scrambled | RKKRRQRRRCLRITRQSR-NH2 |
Sincalide | D-{SO3H-Tyr}-MGWMDF-NH2 |
SIYRY | SIYRYYGL |
SLLK, Control Peptide for TSP1 Inhibitor | SLLK-NH2 |
Small Cardioactive Peptide B SCPB | MNYLAFPRM-NH2 |
SMCY (950-960) (human) | SPSVDKARAEL |
Smcy HY Peptide 738-746 | KCSRNRQYL |
SNAP-25 187-203 | Ac-SNKTRIDEANQRATKML-NH2 |
Somatostatin 28 (1-14) | SANSNPAMAPRERK |
Somatostatin1-14 | AGCKNFFWKTFTSC (C3&C14 bridge) |
Somatostatin-25 | SNPAMAPRERKAGCKNFFWKTFTSC (Disulfide bridge: Cys14-Cys25) |
Somatostatin-28 1-12 | SANSNPAMAPRE |
SPACE peptide | ACTGSTQHQCG (Disulfide bridge: Cys2-Cys10) |
Speract | GFDLNGGGVG |
Sphistin Synthetic Peptide(12-38,Fitc in N-Terminal-Fluorescently Labeled Peptide) | FITC-KAKAKAVSRSARAGLQFPVGRIHRHLK |
ß-Amyloid (25-35) | NH2-GSNKGAIIGLM-COOH |
Substance P (1-9) | RPKPQQFFG |
Substance P (7-11) | FFGLM-NH2 |
Substance P 1-7 | RPKPQQF |
Substance P, Free Acid | RPKPQQFFGLM |
Substrate for Tyrosine Protein Kinase | RRLIEDNEYTARG |
Suc-Leu-Leu-Val-Tyr-AMC | Suc-Leu-Leu-Val-Tyr-AMC |
Super-TDU (1-31) TFA | SVDDHFAKSLGDTWLQIGGSGNPKTANVPQT |
Super-TDU (TFA) | SVDDHFAKSLGDTWLQIGGSGNPKTANVPQTVPMRLRKLPDSFFKPPE |
SV40 large T antigen NLS | CGGGPKKKRKVED |
SV40 T-Ag-derived NLS peptide | PKKKRKVEDPYC |
Syntide 2 | PLARTLSVAGLPGKK |
SYSMEHFRWGKPS | SYSMEHFRWGKPS |
Systemin | AVQSKPPSKRDPPKMQTD |
T7 Tag Peptide | MASMTGGQQMG |
TAK-448 acetate | Ac-Y-{Hyp}-NTFGLRW-NH2 |
TAT | YGRKKRRQRRR-NH2 |
TAT 2-4 | YGRKKRRQRRRGYGRKKRRQRRRG |
TAT 48-57 | GRKKRRQRRR |
TAT peptide | GRKKRRQRRRPQ |
TB500 | Ac-LKKTETQ |
Tetanus toxin 830-843 | QYIKANSKFIGITE |
TFLLR-NH2(TFA) | TFLLR-NH2 |
Thioredoxin reductase peptide | WGLGGTCVNVGCIPK |
Thrombin Receptor Activator for Peptide 5 TRAP-5 | SFLLR |
Thymalfasin | Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN |
Thymopentin | RKDVY |
Thymopoietin II (32-34) | RKD |
Thymopoietin II (32-35) | RKDV |
Thyrotropin-Releasing Hormone (TRH), Free Acid | {pGlu}-HP |
TIP 39, Tuberoinfundibular Neuropeptide | SLALADDAAFRERARLLAALERRHWLNSYMHKLLVLDAP |
Tirzepatide | Y-{Aib}-EGTFTSDYSI-{Aib}-LDKIAQ-{diacid-gamma-Glu-(AEEA)2-Lys}-AFVQWLIAGGPSSGAPPPS-NH2 |
TLQP-30 | TLQPPASSRRRHFHHALPPARHHPDLEAQA |
TNF-α (10-36), human | DKPVAHVVANPQAEGQLQWLNRRANAL |
TNF-α (31-45), human TFA | RRANALLANGVELRD |
TNF-α (46-65), human | NQLVVPSEGLYLIYSQVLFK |
Tos-Gly-Pro-Arg-ANBA-IPA acetate | Tos-GPR-ANBA-IPA |
TP508 | AGYKPDEGKRGDACEGDSGGPFV |
Transportan | GWTLNSAGYLLGKINLKALAALAKKIL-NH2 |
Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp | WNRQLYPEWTEAQRLD |
Tuftsin | TKPR |
Tyr-Ile-Tyr-Gly-Ser-Phe-Lys | YIYGSFK |
Tyrosinase (192-200), human mouse | SEIWRDIDF |
Tyrosinase (206-214), human | AFLPWHRLF |
Tyrosine Protein Kinase JAK 2 Phospho-Tyr8, 9 | VLPQDKE-{pTyr}{pTyr}-KVKEPGE |
Tyr-Somatostatin-14 | YAGCKNFFWKTFTSC (Disulfide bridge: Cys4-Cys15) |
Urechistachykinin I | LRQSQFVGSR-NH2 |
Urechistachykinin II | AAGMGFFGAR-NH2 |
Urocortin II, human | IVLSLDVPIGLLQILLEQARARAAREQATTNARILARVGHC-NH2 |
Urocortin III, human | FTLSLDVPTNIMNLLFNIAKAKNLRAQAAANAHLMAQI-NH2 |
Urocortin III, mouse | FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI-NH2 |
Urocortin III, mouse, free acid | FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI |
Urocortin, human | DNPSLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 |
Urocortin, rat | DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 |
Urotensin I | NDDPPISIDLTFHLLRNMIEMARIENEREQAGLNRKYLDEV-NH2 |
Urotensin II (114-124), human | ETPDCFWKYCV (Disulfide bridge: Cys5-Cys7) |
Urotensin II, mouse | {pGlu}-HGAAPECFWKYCI (Disulfide bridge: Cys8-Cys13) |
Uty HY Peptide 246-254 | WMHHNMDLI |
V5 Epitope Tag Peptide Trifluoroacetate | GKPIPNPLLGLDST |
Vasonatrin Peptide VNP | GLSKGCFGLKLDRIGSMSGLGCNSFRY (Disulfide bridge: Cys6-Cys22) |
VIP(6-28)(human, rat, porcine, bovine) | FTDNYTRLRKQMAVKKYLNSILN-NH2 |
VIP, guinea pig | HSDALFTDTYTRLRKQMAMKKYLNSVLN-NH2 |
VIP, human, porcine, rat, ovine | HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 |
VIR-165 | LEAIPCSIPPCFAFNKPFVF (Disulfide bridge: Cys6-Cys11) |
VSV-G Peptide | YTDIEMNRLGK |
WKYMVM | WKYMV-{d-Met} |
WKYMVM TFA | WKYMVM-NH2 |
Xenin | MLTKFETKSARVKGLSFHPKRPWIL |
Xenopsin | {Glp}-GKRPWIL |
X-press Tag Peptide | DLYDDDDK |
YRGDS Fibronectin Fragment | YRGDS |
Z-Gly-Gly-Arg-AMC | ZGGR-AMC |
Z-VRPR-FMK (TFA) | Z-VRPR-FMK |
α2β1 Integrin Ligand Peptide | DGEA |
α-Bag Cell Peptide (1-7) | APRLRFY |
α-Bag Cell Peptide (1-8) | APRLRFYS |
α-Bag Cell Peptide (1-9) | APRLRFYSL |
α-Casein 90-95 | RYLGYL |
α-Factor Mating Pheromone, yeast | WHWLQLKPGQPMY |
α-Melanocyte-Stimulating Hormone (MSH), amide(α-MSH) | Ac-SYSMEHFRWGKPV-NH2 |
α-MSH | Ac-SYSMEHFRWGKPV-CONH2 |
α-Neoendorphin 1-8 | YGGFLRKY |
β-Amyloid (1-10) | DAEFRHDSGY |
β-Amyloid (1-11) | DAEFRHDSGYE |
β-Amyloid (1-12) | DAEFRHDSGYEV |
β-Amyloid (1-13) | DAEFRHDSGYEVH |
β-Amyloid (1-14) | DAEFRHDSGYEVHH |
β-Amyloid (1-18) | DAEFRHDSGYEVHHQKLV |
β-Amyloid (1-20) | DAEFRHDSGYEVHHQKLVFF |
β-Amyloid (1-28) | DAEFRHDSGYEVHHQKLVFFAEDVGSNK |
β-Amyloid (1-40) | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
β-Amyloid (1-42), human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
β-Amyloid (1-42), rat | DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
β-Amyloid (1-9) | DAEFRHDSG |
β-Amyloid (25-35) | GSNKGAIIGLM |
β-Amyloid 12-20 | VHHQKLVFF |
β-Amyloid 4-10 | FRHDSGY |
β-Bag Cell Factor | RLRFH |
β-Casomorphin (1-3), amide | YPF-NH2 |
β-Casomorphin (1-5), amide, bovine | Y-{d-Ala}-FPM-NH2 |
β-Casomorphin (1-5), bovine | YPFPG |
β-Casomorphin (1-6), bovine | YPFPGP |
β-Casomorphin, bovine | YPFPGPI |
β-Casomorphin, human | YPFVEPI |
β-catenin peptide | RTYTYEKL |
β-CGRP, human TFA | ACNTATCVTHRLAGLLSRSGGMVKSNFVPTNVGSKAF-NH2(Disulfide bridge: Cys2-Cys7) |
β-Endorphin, equine | YGGFMSSEKSQTPLVTLFKNAIIKNAHKKGQ |
β-Melanocyte Stimulating Hormone (MSH), human TFA | AEKKDEGPYRMEHFRWGSPPKD |
γ-1-Melanocyte Stimulating Hormone (MSH), amide | YVMGHFRWDRF-NH2 |
γ-2-MSH (41-58), amide | YVMGHFRWDRFG-NH2 |
γ-Bag Cell Factor | RLRFD |
γ-Glu-Phe | γ-Glu-Phe |